How Lumenci built an eight-figure valuation on infringement evidence, not comparables
Most portfolio valuations are built from comparable deals.
Lumenci built this one from claim charts mapping the patents to products already shipping in the market.
Case at a Glance
Domain
Service
Client
Outcome
An eight-figure portfolio valuation, built on charted evidence and tested by four filings.
Most valuations tell you what similar patents sold for. This one told the client who was already using theirs.
What most teams do.
What Lumenci did instead.
Built the valuation on claim charts mapping the patents to products already shipping in the market.
Why it mattered.
How It Was Done
Lumenci ran the programme end to end, staffed with engineers who know virtualization and containerization and analysts who know what a licensing counterparty will attack in a valuation.
%20(convert.io).webp?width=960&height=678&name=patent%20portfolio%20(49)%20(convert.io).webp "patent portfolio (49) (convert.io)")
A broad virtualization and containerization portfolio was assessed to isolate the patents with genuine market applicability, separating assets with infringement potential from those with none.
Products and vendors practicing the claimed technologies were identified across the market, establishing who the portfolio actually reads on.
Core claims were mapped to real-world implementations in shipping products, producing the evidence both the valuation and any assertion would rest on.
The valuation was built on the charted evidence, so every figure traced back to a specific patent against a specific product rather than to comparable deal data.
Licensing pathways and litigation readiness were set out against the client's business goals and exit timeline.
What Changed for the Client
Where they stood.
An eight-figure valuation where every figure traced to a specific patent against a specific shipping product
What it forced.
Anyone at the negotiating table was looking at mapped evidence of use, not an assertion that the portfolio was valuable
Where it stands.
Four litigations initiated on the core virtualization assets, with the valuation model supporting ongoing investor discussions
Patent Valuation and Portfolio Monetization
1000+ Campaigns
100k+ Patents Analyzed
250+ Litigations Supported
What This Would Look Like for Your Matter
A scoping conversation covers the portfolio, your exit or licensing timeline, which technologies you believe are being practiced, and how much evidence you already have. You get a view of which assets can carry a valuation before committing to a full programme.
Frequently Asked Questions
What makes a patent valuation credible in a licensing negotiation?
Evidence of use. A number built from comparable transactions describes what other portfolios sold for. A number built from claim charts describes what this portfolio reads on, and the second is much harder for a prospective licensee to argue with.
How do you decide which patents in a large portfolio are worth asserting?
By working outward from the market rather than inward from the claims. The question is which technologies are actually being implemented in shipping products, then which of your patents read on those implementations cleanly enough to survive challenge.
Does a valuation need claim charts?
Not always, but a valuation intended to support licensing or litigation does. Without charted evidence the number rests on analogy to other deals, and the first serious counterparty will say so.
How long does patent monetization take to show a result?
Licensing and litigation run on multi-year timelines. What can be delivered early is the analysis the whole programme depends on: which assets carry value, who is practicing them, and what the portfolio is worth on evidence.
Can Lumenci carry a portfolio from valuation through to litigation support?
Yes. On this matter the same team ran portfolio mining, claim charting, and valuation, and the assets carrying the valuation were the ones assessed for assertion. Lumenci also provides IP litigation support once matters are filed.
Is claim charting available as a standalone service?
Yes. Claim charting is frequently the first engagement, whether the goal is licensing outreach, a valuation, or pre-filing assessment.